Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial

Simone Augustinus^{1

2}, Thijmen Broekman^{2

3}, Geert-Jan Creemers⁴, Lois A Daamen^{5

6}, Susan van Dieren^{1

2}, Jan-Willem B de Groot⁷, Geert A Cirkel⁸, Marjolein Y V Homs⁹, Hanneke W M van Laarhoven^{2

3}, Lobke van Leeuwen¹⁰, Maartje Los¹¹, Saskia A C Luelmo¹², Martijn G H van Oijen^{2

3}, Leontine E A M Spierings¹³, Judith de Vos-Geelen¹⁴, Marc G Besselink^{1

2}, Johanna W Wilmink^{2

3}; Dutch Pancreatic Cancer Group

Affiliations

¹ Amsterdam UMC, Department of Surgery, University of Amsterdam, Amsterdam, The Netherlands.
² Cancer Center Amsterdam, Amsterdam, The Netherlands.
³ Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, The Netherlands.
⁴ Department of Medical Oncology, Catherina Hospital, Eindhoven, The Netherlands.
⁵ Division of Imaging & Oncology, University Medical Center Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
⁶ Department of Surgery, University Medical Center Utrecht Cancer Center, St Antonius Hospital Nieuwegein, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
⁷ Department of Medical Oncology, Oncology Center Isala, Zwolle, The Netherlands.
⁸ Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Meander Medisch Centrum, Amersfoort, The Netherlands.
⁹ Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.
¹⁰ Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Diakonessenhuis, Utrecht, The Netherlands.
¹¹ Department of Medical Oncology, Regional Academic Cancer Center Utrecht, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands.
¹² Department of Medical Oncology, Leids Universitair Medisch Centrum, Leiden, The Netherlands.
¹³ Department of Medical Oncology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands.
¹⁴ Department of Medical Oncology, GROW, Maastricht UMC, Maastsricht, The Netherlands.

Simone Augustinus et al. Acta Oncol. 2023 Dec.

. 2023 Dec;62(12):1973-1978.

doi: 10.1080/0284186X.2023.2273898. Epub 2023 Nov 25.

¹ Amsterdam UMC, Department of Surgery, University of Amsterdam, Amsterdam, The Netherlands.
² Cancer Center Amsterdam, Amsterdam, The Netherlands.
³ Amsterdam UMC, Department of Medical Oncology, University of Amsterdam, Amsterdam, The Netherlands.
⁴ Department of Medical Oncology, Catherina Hospital, Eindhoven, The Netherlands.
⁵ Division of Imaging & Oncology, University Medical Center Utrecht Cancer Center, Utrecht University, Utrecht, The Netherlands.
⁶ Department of Surgery, University Medical Center Utrecht Cancer Center, St Antonius Hospital Nieuwegein, Regional Academic Cancer Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
⁷ Department of Medical Oncology, Oncology Center Isala, Zwolle, The Netherlands.
⁸ Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Meander Medisch Centrum, Amersfoort, The Netherlands.
⁹ Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.
¹⁰ Department of Medical Oncology, Regional Academic Cancer Center Utrecht, Diakonessenhuis, Utrecht, The Netherlands.
¹¹ Department of Medical Oncology, Regional Academic Cancer Center Utrecht, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands.
¹² Department of Medical Oncology, Leids Universitair Medisch Centrum, Leiden, The Netherlands.
¹³ Department of Medical Oncology, Alrijne Ziekenhuis, Leiderdorp, The Netherlands.
¹⁴ Department of Medical Oncology, GROW, Maastricht UMC, Maastsricht, The Netherlands.

No abstract available

MeSH terms